Suven Life Sciences Limited (BOM:530239)
India · Delayed Price · Currency is INR 136.90
+1.65 (1.22%)
At close: Jan 22, 2026
Suven Life Sciences Market Cap
Suven Life Sciences has a market cap or net worth of 31.14 billion as of January 23, 2026. Its market cap has increased by 10.96% in one year.
Market Cap
31.14B
Enterprise Value
28.57B
Revenue
58.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
136.90
Market Cap Chart
Since July 31, 2002, Suven Life Sciences's market cap has increased from 1.61B to 31.14B, an increase of 1,832.44%. That is a compound annual growth rate of 13.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 31.14B | -17.95% |
| Dec 31, 2025 | 37.95B | 35.97% |
| Dec 31, 2024 | 27.91B | 58.69% |
| Dec 29, 2023 | 17.59B | 17.75% |
| Dec 30, 2022 | 14.94B | 31.72% |
| Dec 31, 2021 | 11.34B | -1.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 174.23B |
| Sudeep Pharma | 60.82B |
| Shilpa Medicare | 54.48B |
| Gujarat Themis Biosyn | 36.48B |
| IOL Chemicals and Pharmaceuticals | 21.01B |
| Bajaj HealthCare | 11.56B |
| NGL Fine-Chem | 9.43B |
| Anlon Healthcare | 6.75B |